Monthly Archives: April 2022

• 

Metastasectomy and survival in kidney cancer patients

By Sharon Deveson Kell|2022-04-27T07:11:32+00:0027 Apr 2022|Surgery|

Metastasectomy is surgery to remove one or more tumours that [...]

Read More

Comments Off on Metastasectomy and survival in kidney cancer patients

• 

Cabozantinib for collecting duct carcinoma

By Sharon Deveson Kell|2022-04-26T13:39:28+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

Collecting duct carcinoma is a rare and aggressive form of [...]

Read More

Comments Off on Cabozantinib for collecting duct carcinoma

• 

EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

By Sharon Deveson Kell|2022-04-26T08:39:32+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Read More

Comments Off on EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

• 

EIKCS 2022: Radiotherapy for kidney cancer

By Sharon Deveson Kell|2022-04-26T07:22:12+00:0026 Apr 2022|Drug treatments, Surgery|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Read More

Comments Off on EIKCS 2022: Radiotherapy for kidney cancer

• 

EIKCS 2022: Care for the whole patient

By Sharon Deveson Kell|2022-04-25T13:37:29+00:0025 Apr 2022|Patient advocacy|

At the 2022 European International Kidney Cancer Symposium (EIKCS) in [...]

Read More

Comments Off on EIKCS 2022: Care for the whole patient

• 

EIKCS 2022: Debate about later-line treatments

By Sharon Deveson Kell|2022-04-25T13:44:50+00:0025 Apr 2022|Drug treatments|

At the 2022 European International Kidney Cancer Symposium (EIKCS) in [...]

Read More

Comments Off on EIKCS 2022: Debate about later-line treatments

• 

EIKCS 2022: Which is the best combination therapy?

By Sharon Deveson Kell|2022-04-25T13:45:22+00:0025 Apr 2022|Drug treatments|

During 2022 European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Read More

Comments Off on EIKCS 2022: Which is the best combination therapy?

• 

EIKCS 2022: Real world use of immunotherapy and survival in metastatic kidney cancer

By Sharon Deveson Kell|2022-04-25T13:45:48+00:0025 Apr 2022|Drug treatments, Uncategorized|

At the 2022 European International Kidney Cancer Symposium (EIKCS) in [...]

Read More

Comments Off on EIKCS 2022: Real world use of immunotherapy and survival in metastatic kidney cancer

• 

EIKCS 2022: Novel combination therapy shows promise in advanced kidney cancer

By Sharon Deveson Kell|2022-04-25T08:34:30+00:0025 Apr 2022|Drug treatments|

A combination therapy with a new targeted therapy (tyrosine kinase [...]

Read More

Comments Off on EIKCS 2022: Novel combination therapy shows promise in advanced kidney cancer

• 

Improving care for kidney cancer patients

By Sharon Deveson Kell|2022-04-20T07:01:12+00:0020 Apr 2022|Patient advocacy|

The International Kidney Cancer Coalition (IKCC), of which Rose Woodward [...]

Read More

Comments Off on Improving care for kidney cancer patients